Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 28 Apr 2025

Comparative study of subacute combined degeneration of the spinal cord due to nitrous oxide abuse and vitamin B12 deficiency

in Multiple Sclerosis and Neuroimmunology

Sedine Marie Desiree Nina Agbo
Xiaohui Duan
Li Wang
Mingrui Dong
Qian Wang
Xiaojing Cai
Fang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1567541

Review

Published on 25 Apr 2025

Controversies and insights into cytokine regulation of neurogenesis and behavior in adult rodents

in Multiple Sclerosis and Neuroimmunology

Rodrigo Daniel Sepúlveda-Cuéllar
Diego Alberto Soria-Medina
Irma Cañedo-Solares
Fernando Gómez-Chávez
Liliana Monserrat Molina-López
María Yolanda Cruz-Martínez
Dolores Correa

Frontiers in Immunology

doi 10.3389/fimmu.2025.1550660

323 views

Review

Accepted on 23 Apr 2025

The role of microglia in multiple sclerosis: implications for treatment with Bruton's tyrosine kinase inhibitors

in Multiple Sclerosis and Neuroimmunology

Patrick Vermersch
Laura Airas
Thomas Berger
Florian Deisenhammer
Nikolaos Grigoriadis
Hans-Peter Hartung
Melinda Magyari
Veronica Popescu
Carlo Pozzilli
Maura Pugliatti

Frontiers in Immunology

doi 10.3389/fimmu.2025.1495529

Case Report

Accepted on 23 Apr 2025

Unilateral Relapsing Primary Central Nervous System Vasculitis -Expanding the Phenotype

in Multiple Sclerosis and Neuroimmunology

Turlough Montague
Jenny Han
Emily Cheung
Jeannette Lechner-Scott
John Parratt

Frontiers in Immunology

doi 10.3389/fimmu.2025.1502022

Opinion

Accepted on 23 Apr 2025

Proteomics Reveals Molecular Subtypes in Traumatic Brain Injury Patients: New Perspectives for Precision Treatment Strategies

in Multiple Sclerosis and Neuroimmunology

Suqin Zhang
Qi Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1606268

189 views

Original Research

Published on 22 Apr 2025

Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients

in Multiple Sclerosis and Neuroimmunology

Ana I. Rodriguez-Perez
Gemma Serrano-Heras
Carmen M. Labandeira
Laura Camacho-Meño
Beatriz Castro-Robles
Juan A. Suarez-Quintanilla
Mónica Muñoz-López
Pepa Piqueras-Landete
María J. Guerra
Tomas Segura

Frontiers in Immunology

doi 10.3389/fimmu.2025.1571027

699 views

Review

Accepted on 21 Apr 2025

From Sensation to Regulation: The Diverse Functions of Peripheral Sensory nervous system

in Multiple Sclerosis and Neuroimmunology

Yi-Xiao Mei
Bing-Lin Zhou
Da Zhong
Xuan-Jie Zheng
Yu-Tao Deng
Lina Yu
Bao-Chun Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1575917

115 views

Review

Accepted on 21 Apr 2025

Translational Insights from EAE Models：Decoding MOGAD Pathogenesis and Therapeutic Innovation

in Multiple Sclerosis and Neuroimmunology

Yanjia Zhang
Dong Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1530977

Original Research

Published on 17 Apr 2025

Shared circulating diagnostic biomarkers and molecular mechanisms in ischemic stroke and systemic lupus erythematosus

in Multiple Sclerosis and Neuroimmunology

Xiaoyi Ma
Lifei Huang
Huanhuan Yan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565379

277 views

Original Research

Published on 16 Apr 2025

The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm

in Multiple Sclerosis and Neuroimmunology

Robert Hoffrogge
Anna Karachunskaya
Neele Heitmann
Xiomara Pedreiturria
Katharina Klöster
Verian Bader
Konstanze F. Winklhofer
Michael Hamacher
Bert Klebl
Ralf Gold

Frontiers in Immunology

doi 10.3389/fimmu.2025.1554999

407 views

Original Research

Published on 15 Apr 2025

Comparison of commercial and in-house tissue-based and cell-based assays for the detection of autoantibodies targeting neuronal surface proteins: a prospective cohort study

in Multiple Sclerosis and Neuroimmunology

David Goncalves
Marie Benaiteau
Véronique Rogemond
Sterenn Closs
Anne-Laurie Pinto
Maroua Dhairi
Marine Villard
Géraldine Picard
Nicole Fabien
Jérôme Honnorat

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563877

355 views

Original Research

Accepted on 14 Apr 2025

Development and Validation of Predictive models for Meige Syndrome Patients based on Oxidative Stress Markers

in Multiple Sclerosis and Neuroimmunology

Yingjie Zhu
Runing Fu
Ziang Wang
Xinjie Zhu
Pengbo Feng
Xinyu Feng
Wenping Lian

Frontiers in Immunology

doi 10.3389/fimmu.2025.1536109

111 views

Review

Accepted on 14 Apr 2025

Astrocyte-Mediated Inflammatory Responses in Traumatic Brain Injury: Mechanisms and Potential Interventions

in Multiple Sclerosis and Neuroimmunology

Haifeng Zhang
Xian Zhang
Yan Chai
yuhua wang
Jianning Zhang
Xin Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1584577

139 views

Original Research

Published on 11 Apr 2025

Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)

in Multiple Sclerosis and Neuroimmunology

Julian Reza Kretschmer
Daria Tkachenko
Tania Kümpfel
Joachim Havla
Daniel Engels
Friedemann Paul
Patrick Schindler
Judith Bellmann-Strobl
Achim Berthele
Katrin Giglhuber

Frontiers in Immunology

doi 10.3389/fimmu.2025.1575613

879 views

Case Report

Published on 04 Apr 2025

Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series

in Multiple Sclerosis and Neuroimmunology

Regina Berkovich
Jonathan Calkwood
Heidi Crayton
April Erwin
Simon Faissner
Ralf Gold
Joshua Katz
Mark Leekoff

Frontiers in Immunology

doi 10.3389/fimmu.2025.1527102

2,224 views

Mini Review

Published on 02 Apr 2025

The role of NLRP3 inflammasome in multiple sclerosis: pathogenesis and pharmacological application

in Multiple Sclerosis and Neuroimmunology

Wen-Gang Zhang
Xiao-Rui Zheng
Yi Yao
Wei-Jia Sun
Bo-Zong Shao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1572140

1,030 views